The CMS national coverage determination (NCD) for TAVR:

  1. Requires that both an interventional cardiologist and cardiac surgeon perform all procedures.
  2. Requires participation in a registry only for off label use.
  3. Restricts the use of TAVR to only the transfemoral approach.
  4. Requires an STS mortality risk score of > 20%.

Answer: A.

Rationale: This is required for all procedures via any FDA approved approach. Participation in a national registry is required for all patients irrespective of use. The NCD allows any approach be reimbursed provided the system being used and the approach have been approved by the FDA. An STS score is not specifically required but 2 cardiac surgeons who have evaluated the patient face-to-face must agree that the patient is high risk for SAVR.


Register today for ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course and you will receive the Board prep you require and the latest information you need for your patients!

New this year! Get the latest updates on the hot topics you won't see on the Board but need to know!

Attend the optional concurrent session on Friday afternoon featuring the information you need on TAVR and CTO including:

  • Anatomy and Pathology of CTOs
  • Adjunctive Imaging during TAVR
  • Antegrade and Retrograde Approaches
  • Contrast and Radiation Considerations in CTO
  • Importance and Management of Perivalvular Leaks

ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course is THE course that will prepare you for the Boards and beyond!

Don't delay — learn more and take advantage of the lowest registration rates today.